Very interesting statement by prof himself one year ago:
Biotech Daily
Friday March 15, 2019 Daily news on ASX-listed biotechnology companies Dr Boreham’s Crucible: Mesoblast By TIM BOREHAM
Mesoblast founder and CEO Prof Silviu Itescu says he’s “95 percent” certain the stem cell drug developer is on the cusp of doing what no other Aussie biotech in phase III trial stage has done in its own right: winning US Food and Drug Administration approval for a new therapy...
Very interesting statement by prof himself one year ago:Biotech...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |